Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryogenically milled tire tread induces functional and structural changes in natural periphyton communities.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Human and zebrafish mineralocorticoid receptors reporter cell assays to assess the activity of chemicals.

iScience·2025
Same author

Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY).

International journal of cardiology·2025
Same author

Biomarkers of residual risk and all-cause mortality after acute coronary syndrome.

American journal of preventive cardiology·2025
Same author

Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics.

Panminerva medica·2024
Same author

Human and fish differences in steroid receptors activation: A review.

The Science of the total environment·2024

Related Experiment Video

Updated: May 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Statin and clopidogrel pharmacological interaction].

Mario Leoncini, Anna Toso, Mauro Maioli

    Giornale Italiano Di Cardiologia (2006)
    |August 2, 2013
    PubMed
    Summary

    Clopidogrel response varies due to drug interactions, especially with atorvastatin. Switching to non-CYP3A4 statins or using high-dose atorvastatin can improve clopidogrel effectiveness in patients with high platelet reactivity.

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Drug Metabolism

    Background:

    • Clopidogrel is a prodrug requiring hepatic activation by cytochrome P450 (CYP) enzymes, primarily CYP2C19 and CYP3A4/5.
    • Patient response to clopidogrel varies, with high on-treatment platelet reactivity increasing the risk of adverse cardiovascular events.
    • Drug-drug interactions, particularly with CYP3A4-metabolized statins like atorvastatin, can affect clopidogrel activation and efficacy.

    Purpose of the Study:

    • To investigate strategies for improving clopidogrel response in patients with high on-treatment platelet reactivity.
    • To evaluate the impact of statin choice and dosage on clopidogrel pharmacodynamics.
    • To explore alternatives to mitigate negative drug-drug interactions between clopidogrel and statins.

    Main Methods:

    Related Experiment Videos

    Last Updated: May 9, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    • Review of pharmacodynamic studies examining clopidogrel and statin interactions.
    • Analysis of studies comparing switching to non-CYP3A4-metabolized statins (rosuvastatin, pravastatin) versus continuing atorvastatin.
    • Assessment of the effect of high-dose atorvastatin on clopidogrel pharmacodynamics in statin-naïve patients.

    Main Results:

    • Switching from low-dose atorvastatin to rosuvastatin or pravastatin significantly decreased platelet reactivity in patients on clopidogrel.
    • High-dose atorvastatin (80mg) for 30 days improved clopidogrel's pharmacodynamic effects, reducing platelet reactivity.
    • Atorvastatin's enhancement of clopidogrel effects appears dose-dependent and independent of LDL cholesterol reduction.

    Conclusions:

    • Switching to a non-CYP3A4-metabolized statin is a viable strategy for patients with high platelet reactivity on clopidogrel and low-dose atorvastatin.
    • High-dose atorvastatin administration can also improve clopidogrel response, offering an alternative for statin-naïve patients.
    • These strategies can help avoid negative drug-drug interactions and optimize individual patient response to clopidogrel therapy.